Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Droppa

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Plos One|March 24, 2015
Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE)Michal Droppa, Dimitri Tschernow, Karin A L Müller, et al.
Atherosclerosis|October 21, 2018
Relative survival potential of platelets is associated with platelet CXCR4/CXCR7 surface exposure and functional recovery following STEMIDominik Rath, Madhumita Chatterjee, Lennart Meyer, et al.
Pharmacogenomics and Personalized Medicine|July 29, 2021
C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery DiseaseJessica Kristin Henes, Patrick Groga-Bada, Elke Schaeffeler, et al.
Plos One|August 29, 2015
High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and ClopidogrelTobias Geisler, Jean Booth, Elli Tavlaki, et al.
International Journal of Cardiology|February 11, 2017
Immediate increase of cardiac output after percutaneous mitral valve repair (PMVR) determined by echocardiographic and invasive parameters: Patzelt: Increase of cardiac output after PMVRJohannes Patzelt, Yingying Zhang, Harry Magunia, et al.
Journal of the American Heart Association|December 4, 2017
Comparison of Deep Sedation With General Anesthesia in Patients Undergoing Percutaneous Mitral Valve RepairJohannes Patzelt, Miriam Ulrich, Harry Magunia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trialTobias Geisler, Michal Droppa, Meinrad Gawaz, et al.
Thrombosis and Haemostasis|August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and PracticeTobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
Heart and Vessels|June 28, 2020
Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesisMichal Droppa, Tanja K Rudolph, Jan Baan, et al.
Plos One|October 20, 2018
Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MRJohannes Patzelt, Miriam Ulrich, Annika Becker, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Plos One|March 24, 2015
Evaluation of clinical risk factors to predict high on-treatment platelet reactivity and outcome in patients with stable coronary artery disease (PREDICT-STABLE)Michal Droppa, Dimitri Tschernow, Karin A L Müller, et al.
Atherosclerosis|October 21, 2018
Relative survival potential of platelets is associated with platelet CXCR4/CXCR7 surface exposure and functional recovery following STEMIDominik Rath, Madhumita Chatterjee, Lennart Meyer, et al.
Pharmacogenomics and Personalized Medicine|July 29, 2021
C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery DiseaseJessica Kristin Henes, Patrick Groga-Bada, Elke Schaeffeler, et al.
Plos One|August 29, 2015
High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and ClopidogrelTobias Geisler, Jean Booth, Elli Tavlaki, et al.
International Journal of Cardiology|February 11, 2017
Immediate increase of cardiac output after percutaneous mitral valve repair (PMVR) determined by echocardiographic and invasive parameters: Patzelt: Increase of cardiac output after PMVRJohannes Patzelt, Yingying Zhang, Harry Magunia, et al.
Journal of the American Heart Association|December 4, 2017
Comparison of Deep Sedation With General Anesthesia in Patients Undergoing Percutaneous Mitral Valve RepairJohannes Patzelt, Miriam Ulrich, Harry Magunia, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 3, 2015
Impact of anticoagulation regimen prior to revascularization in patients with non-ST-segment elevation acute coronary syndromes: The ACUITY trialTobias Geisler, Michal Droppa, Meinrad Gawaz, et al.
Thrombosis and Haemostasis|August 18, 2019
Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and PracticeTobias Geisler, Rezo Jorbenadze, Aron-Frederik Popov, et al.
Heart and Vessels|June 28, 2020
Risk factors for permanent pacemaker implantation in patients receiving a balloon-expandable transcatheter aortic valve prosthesisMichal Droppa, Tanja K Rudolph, Jan Baan, et al.
Plos One|October 20, 2018
Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MRJohannes Patzelt, Miriam Ulrich, Annika Becker, et al.
Pageof 5